Dr. Barry is Professor of Medicine in the Center for Vaccine Development and Global Health at the University of Maryland School of Medicine. She is a molecular microbiologist with over 20 years of experience identifying mechanisms of bacterial pathogenesis using novel model systems, including the human enteroid “mini gut” model, and developing vaccines. Her focus has been on the enteric pathogens Shigella and enterotoxigenic E. coli (ETEC), which are responsible for significant global diarrheal disease burden. The current strategy utilizes a platform of live attenuated Shigella vaccine strains to serve as live vectors expressing critical ETEC antigens forming a multivalent vaccine to prevent disease caused by two important pathogens. She is committed to training the next generation of biomedical scientists and leads a diverse team that includes graduate students, postdoctoral fellows, and research assistants.